HAI
ALXN

Hennessy Advisors Inc’s Alexion Pharmaceuticals ALXN Stock Holding History

Hennessy Advisors Inc’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-5,260
Closed -$629K – 446
2017
Q4 		$629K Buy
+5,260
New +$641K 0.02% 305
2014
Q2 		– Sell
-1,920
Closed -$292K – 310
2014
Q1 		$292K Sell
1,920
-85
-4% -$13.5K 0.01% 299
2013
Q4 		$267K Sell
2,005
-125
-6% -$15K 0.01% 312
2013
Q3 		$247K Buy
+2,130
New +$234K 0.01% 314

Other funds holding ALXN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Hennessy Advisors Inc's ALXN Position: Q1 2018 in Review

Hennessy Advisors Inc sold out of Alexion Pharmaceuticals (ALXN) in Q1 2018, closing a stake of 5,260 shares — an estimated $629K sold.

Hennessy Advisors Inc first reported a position in ALXN in Q3 2013 and held it in 4 quarters. The position peaked at $629K in Q4 2017. 597 funds tracked by Wall St. Rank hold ALXN as of Q1 2018.

  • Hennessy Advisors Inc reported no remaining Alexion Pharmaceuticals position as of Q1 2018 after selling out during the quarter.
  • Hennessy Advisors Inc sold 5,260 Alexion Pharmaceuticals shares in Q1 2018, an estimated $629K.
  • Hennessy Advisors Inc first reported a position in Alexion Pharmaceuticals in Q3 2013 and held it in 4 quarters.
  • Hennessy Advisors Inc's Alexion Pharmaceuticals position peaked at $629K in Q4 2017.
  • 597 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q1 2018.

Based on Hennessy Advisors Inc's 13F filing for Q1 2018, filed 2 May 2018.